[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cytek Biosciences Inc (CTKB)

Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 544,983
  • Shares Outstanding, K 129,143
  • Annual Sales, $ 201,490 K
  • Annual Income, $ -66,540 K
  • EBIT $ -44 M
  • EBITDA $ -32 M
  • 60-Month Beta 1.17
  • Price/Sales 2.76
  • Price/Cash Flow N/A
  • Price/Book 1.70

Options Overview Details

View History
  • Implied Volatility 341.06% (-142.40%)
  • Historical Volatility 40.96%
  • IV Percentile 39%
  • IV Rank 30.79%
  • IV High 1,024.36% on 01/09/26
  • IV Low 37.01% on 09/05/25
  • Expected Move (DTE 19) 0.00 (0.00%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 68
  • Open Int (30-Day) 153
  • Expected Range 4.22 to 4.22

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.06
  • Number of Estimates 1
  • High Estimate $-0.06
  • Low Estimate $-0.06
  • Prior Year $-0.04
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.14 +2.06%
on 07/31/26
4.80 -11.99%
on 07/16/26
-0.21 (-4.74%)
since 06/30/26
3-Month
3.31 +27.49%
on 05/14/26
4.99 -15.43%
on 05/07/26
-0.34 (-7.46%)
since 04/30/26
52-Week
3.28 +28.66%
on 09/25/25
6.18 -31.72%
on 11/17/25
+0.67 (+18.87%)
since 07/30/25

Business Summary

Cytek Biosciences Inc provides cell analysis solutions. The company developed high-resolution, high-content and high-sensitivity cell analysis technology called Full Spectrum Profiling. Cytek Biosciences Inc is based in FREMONT, Calif.

See More

Key Turning Points

3rd Resistance Point 4.48
2nd Resistance Point 4.40
1st Resistance Point 4.31
Last Price 4.22
1st Support Level 4.13
2nd Support Level 4.05
3rd Support Level 3.96

See More

52-Week High 6.18
Fibonacci 61.8% 5.07
Fibonacci 50% 4.73
Fibonacci 38.2% 4.39
Last Price 4.22
52-Week Low 3.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.